Amrubicin Shows Encouraging Results for Small Cell Lung Cancer Treatment
...rubicin, the company's third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. These findings indicate favorable interim results in terms of response rate and safety when comparing Amrubicin to the current treatment standard, topotecan, in second-line treat...Researchers Analyzes Risk Between Hodgkin Disease and Heart Attack Mortality
...py above the diaphragm] but may also be related to anthracycline and vincristine treatment." "Long-term studies that follow lymphoma survivors for many years, such as the one conducted by Swerdlow and colleagues, are needed to help better understand the processes and factors that worsen heart function, especial...Longer Anthracycline Therapy Reduces Heart Failure in Adult Cancer Patients
... at controlling cancer, but heart damage caused by anthracycline treatment “is a considerable and serious problem,”...es of heart failure among adult patients receiving anthracycline therapy were significantly lower when the patients had an infusion of the drug that lasted six or mo...